Published in Front Cell Neurosci on August 25, 2014
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol Autism (2017) 1.38
Autism spectrum disorders: emerging mechanisms and mechanism-based treatment. Front Cell Neurosci (2015) 0.82
Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome. Proc Natl Acad Sci U S A (2015) 0.81
Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information? Brain Sci (2015) 0.80
Neuron class-specific requirements for Fragile X Mental Retardation Protein in critical period development of calcium signaling in learning and memory circuitry. Neurobiol Dis (2016) 0.80
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord (2017) 0.77
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry (2017) 0.77
Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci (2015) 0.77
Fragile X mental retardation protein knockdown in the developing Xenopus tadpole optic tectum results in enhanced feedforward inhibition and behavioral deficits. Neural Dev (2016) 0.77
Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome. J Biol Chem (2017) 0.75
Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic Dysfunction. Acta Naturae (2017) 0.75
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Interneurons of the neocortical inhibitory system. Nat Rev Neurosci (2004) 13.33
Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science (2008) 9.24
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature (2003) 7.49
Correction of fragile X syndrome in mice. Neuron (2007) 6.51
Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45
Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature (1995) 6.33
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
High-frequency network oscillation in the hippocampus. Science (1992) 5.59
Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science (2000) 5.27
Differences between somatic and dendritic inhibition in the hippocampus. Neuron (1996) 4.85
Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature (1994) 4.63
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron (2012) 4.31
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology (2005) 4.09
Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing connexin36. Neuron (2001) 3.90
Perisomatic inhibition. Neuron (2007) 3.79
Advances in the treatment of fragile X syndrome. Pediatrics (2009) 3.10
A network of electrically coupled interneurons drives synchronized inhibition in neocortex. Nat Neurosci (2000) 2.88
The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci (2006) 2.59
Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet A (2004) 2.58
Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol (2008) 2.46
Hippocampal pyramidal cells excite inhibitory neurons through a single release site. Nature (1993) 2.37
Activity-dependent neuronal signalling and autism spectrum disorder. Nature (2013) 2.23
The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev (2002) 2.15
Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet (2009) 2.12
Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J Pharmacol Exp Ther (2005) 2.08
A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron (2003) 2.05
Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex. J Neurophysiol (2008) 1.97
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature (2004) 1.92
Precision and variability in postsynaptic target selection of inhibitory cells in the hippocampal CA3 region. Eur J Neurosci (1993) 1.85
Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J Neurosci (2008) 1.72
Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron (2010) 1.72
Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res (2006) 1.70
Delayed stabilization of dendritic spines in fragile X mice. J Neurosci (2010) 1.69
Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci (2010) 1.69
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci (2012) 1.49
Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci U S A (2010) 1.45
Networks of parvalbumin-positive interneurons in the basolateral amygdala. J Neurosci (2007) 1.44
Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard (2008) 1.43
Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia (1999) 1.42
Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett (2006) 1.40
Beta and gamma frequency synchronization by dendritic gabaergic synapses and gap junctions in a network of cortical interneurons. J Neurosci (2001) 1.36
Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis (2005) 1.34
Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J Neurosci (2011) 1.32
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci (2010) 1.24
Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet (1996) 1.24
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun (2012) 1.24
Circuit level defects in the developing neocortex of Fragile X mice. Nat Neurosci (2013) 1.23
Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci (2010) 1.22
Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet A (2008) 1.20
The roles of somatostatin-expressing (GIN) and fast-spiking inhibitory interneurons in UP-DOWN states of mouse neocortex. J Neurophysiol (2010) 1.20
Autism-lessons from the X chromosome. Soc Cogn Affect Neurosci (2006) 1.18
Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev Neurosci (2011) 1.18
M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes. J Neurosci (2010) 1.15
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology (2010) 1.14
Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT(3A)R expression. Nat Neurosci (2013) 1.09
Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunits. Neuropharmacology (2011) 1.07
Impaired inhibitory control of cortical synchronization in fragile X syndrome. J Neurophysiol (2011) 1.05
Inhibition and synchronization of basal amygdala principal neuron spiking by parvalbumin-positive interneurons. J Neurophysiol (2007) 1.05
The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev Neurosci (2011) 1.04
Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Hum Mol Genet (2012) 1.04
Sensitive time-windows for susceptibility in neurodevelopmental disorders. Trends Neurosci (2012) 1.02
Altered auditory processing in a mouse model of fragile X syndrome. Brain Res (2013) 1.01
Origins of epilepsy in fragile X syndrome. Epilepsy Curr (2009) 1.00
Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Hum Mol Genet (2013) 0.99
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res (2012) 0.96
CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J Pharmacol Exp Ther (2011) 0.96
Auditory change detection in fragile X syndrome males: a brain potential study. Clin Neurophysiol (2011) 0.95
A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons. J Neurosci (2013) 0.95
Impaired critical period plasticity in primary auditory cortex of fragile X model mice. J Neurosci (2013) 0.89
Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala. J Neurophysiol (2014) 0.87
Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome. Cereb Cortex (2013) 0.84
Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol Psychol (2012) 0.83
Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice. Cereb Cortex (2013) 0.83
Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation. J Neurophysiol (2012) 0.83
Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome. J Neurosci (2013) 0.81
Fear-specific amygdala function in children and adolescents on the fragile x spectrum: a dosage response of the FMR1 gene. Cereb Cortex (2012) 0.80
Developmental changes in expression of inhibitory neuronal proteins in the Fragile X Syndrome mouse basolateral amygdala. Brain Res (2013) 0.79
Regulation of GABAA receptors by fragile X mental retardation protein. Int J Physiol Pathophysiol Pharmacol (2013) 0.78
Emotion recognition and visual-scan paths in Fragile X syndrome. J Autism Dev Disord (2013) 0.78
Amygdala regulation of fear and emotionality in fragile X syndrome. Dev Neurosci (2011) 0.77
Depressed nNOS expression during spine transition in the developing hippocampus of FMR1 KO mice. Braz J Med Biol Res (2012) 0.77
Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome. PLoS One (2012) 0.77
Males but not females show differences in calbindin immunoreactivity in the dorsal thalamus of the mouse model of fragile X syndrome. J Comp Neurol (2013) 0.77
Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice. J Comp Neurol (2011) 0.77